ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	19.47	96	64.21	34.2	13.93
Short-Term Investments	-	0.9	2.84	-	-	-
Cash & Short-Term Investments	46.3	20.37	98.84	64.21	34.2	13.93
Cash Growth	-20.38%	-79.40%	53.95%	87.72%	145.62%	-4.69%
Accounts Receivable	-	1,069	1,035	987.12	977.47	816.55
Other Receivables	-	0.76	0.34	0.28	0.39	1.45
Receivables	-	1,070	1,035	987.4	978.08	818.82
Inventory	-	864.7	812.63	537.06	752.84	543.47
Prepaid Expenses	-	24.01	18.3	17.55	9.81	14.04
Other Current Assets	-	334.04	311.49	303.27	346.43	527.35
Total Current Assets	-	2,313	2,276	1,909	2,121	1,918
Property, Plant & Equipment	-	2,024	1,804	1,216	1,069	1,052
Long-Term Investments	-	0.5	0.52	0.52	0.52	0.52
Goodwill	-	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	-	321.74	224.9	139.21	103.49	117.96
Long-Term Deferred Tax Assets	-	-	-	-	-	26.06
Other Long-Term Assets	-	59.25	160.13	149.3	120.57	131.61
Total Assets	-	4,720	4,468	3,416	3,416	3,248
Accounts Payable	-	695.06	623.81	582.39	810.71	648.71
Accrued Expenses	-	101.38	78.83	83.93	51.18	64.7
Short-Term Debt	-	524.61	550.4	228.8	173.45	446.31
Current Portion of Long-Term Debt	-	194.04	157.12	120.63	150.4	146.41
Current Portion of Leases	-	35.64	24.72	15.72	14.07	10.82
Current Income Taxes Payable	-	29.2	-	-	20.66	-
Current Unearned Revenue	-	3.85	4.88	3.66	4.48	5.3
Other Current Liabilities	-	79.86	154.5	72.74	234.17	98.12
Total Current Liabilities	-	1,664	1,594	1,108	1,459	1,420
Long-Term Debt	-	403.01	356.01	246.25	189.23	218.29
Long-Term Leases	-	20.7	29.5	10.18	7.22	1.68
Long-Term Deferred Tax Liabilities	-	110.5	101.01	48.03	3.63	-
Total Liabilities	-	2,198	2,081	1,412	1,659	1,640
Common Stock	-	487.26	487.26	487.26	162.42	162.42
Additional Paid-In Capital	-	80.3	80.3	80.3	409.89	409.89
Retained Earnings	-	1,701	1,585	1,416	1,177	1,031
Comprehensive Income & Other	-	253.62	234.97	19.61	8.23	4.59
Total Common Equity	2,513	2,522	2,387	2,003	1,757	1,608
Minority Interest	-	0.01	0	-	-	-
Shareholders' Equity	2,513	2,522	2,387	2,003	1,757	1,608
Total Liabilities & Equity	-	4,720	4,468	3,416	3,416	3,248
Total Debt	1,229	1,178	1,118	621.58	534.37	823.51
Net Cash (Debt)	-1,183	-1,158	-1,019	-557.38	-500.17	-809.58
Net Cash Per Share	-24.31	-23.76	-20.91	-11.44	-10.26	-16.63
Filing Date Shares Outstanding	48.86	48.73	48.73	48.73	48.73	48.73
Total Common Shares Outstanding	48.86	48.73	48.73	48.73	48.73	48.73
Working Capital	-	649.43	682.23	801.61	662.27	497.25
Book Value Per Share	53.27	51.77	49.00	41.12	36.06	32.99
Tangible Book Value	2,153	2,199	2,161	1,863	1,652	1,488
Tangible Book Value Per Share	45.63	45.13	44.35	38.23	33.90	30.54
Land	-	96.16	96.16	96.16	96.16	96.16
Buildings	-	819.87	790.03	503.21	471.4	436.39
Machinery	-	1,364	1,338	1,018	943.73	872.98
Construction In Progress	-	440.54	235.16	178.39	50.97	45.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.